New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 4, 2013
07:06 EDTTXMDTherapeuticsMD appoints Joel S. Krasnow as Chief Scientific Officer
TherapeuticsMD announced the appointment of Joel S. Krasnow, M.D., M.B.A., a leading board-certified OB/GYN and reproductive endocrinologist with broad biotech and pharmaceutical experience, as the company's Chief Scientific Officer and head of its regulatory department. Dr. Krasnow joins TherapeuticsMD from Intarcia Therapeutics.
News For TXMD From The Last 14 Days
Check below for free stories on TXMD the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 29, 2014
16:07 EDTTXMDTherapeuticsMD begins phase 3 clinical trial of TX-004HR
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use